Ingevity's Q2 adjusted EBITDA rose to $115 million, driven by favorable pricing, product mix and volumes, prompting higher 2026 earnings guidance.
NGVT's portfolio reshaping, acquisitions and strong cash flow support growth, while APT weakness and macro risks cloud the outlook.
Ingevity NYSE: NGVT is nearing completion of a strategic portfolio transformation that has narrowed its focus to its Performance Materials and Pavement Technologies businesses, President and Chief Executive Officer David Li said during a Water Tower Research conference session.
| Specialty Retail Industry | Consumer Discretionary Sector | David H. Li CEO | XDUS Exchange | US45688C1071 ISIN |
| US Country | 1,500 Employees | - Last Dividend | - Last Split | 2 May 2016 IPO Date |
Ingevity Corporation, headquartered in North Charleston, South Carolina, is a prominent manufacturer and seller of activated carbon products, specialty chemicals, and engineered polymers. Serving a global market, including regions like North America, the Asia Pacific, Europe, the Middle East, Africa, and South America, Ingevity operates through three primary segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Originally part of WestRock Company, it rebranded to Ingevity Corporation in September 2015. Since its foundation in 1964, the company has significantly expanded its product offerings and geographical footprint, providing innovative solutions across a wide array of industries, from automotive emissions control to bioplastics and medical devices.
This segment focuses on engineering and manufacturing activated carbon products derived from hardwood, primarily used in gasoline vapor emission control systems for vehicles such as cars, motorcycles, trucks, and boats. Additionally, Ingevity produces a variety of activated carbon solutions for applications in food, water, beverage, and chemical purification, marking a broad spectrum of industrial and consumer uses.
Encompassing road technologies and industrial specialties, this segment addresses the needs of pavement construction, preservation, and reconstruction, including pavement recycling and road markings. Beyond infrastructure applications, Performance Chemicals also extend to agrochemical dispersants, paper chemicals, and other industrial applications, showcasing Ingevity's versatility and commitment to various sectors.
The Advanced Polymer Technologies segment produces caprolactone and related specialty polymers, which find applications in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It underscores Ingevity's role in advancing polymer science and supporting manufacturers in the automotive parts and components sector, among others, with high-performance materials designed for a wide range of industrial and medical purposes.